Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine Day 0 Prophylaxis for CRS in Haplo-HSCT
NCT04781803Phase 2Unknown
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in cytokine release syndrome (CRS), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Status: unknown.
02
Drugs
cyclosporine
03
Conditions
cytokine release syndrome (CRS)
Beyond the preview
Go deeper on NCT04781803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781803.